Encouraging News At EnWave’s AGM
During the recently held annual meeting (AGM), EnWave Corp’s (CA:ENW – $0.75 & US:NWVCF – $0.53 & GER:E4U – €0.51) management mentioned that it is receiving lots of interest from pharmaceutical companies for its REV-dried technology. These enquiries are being handled by EnWave’s partner GEA, with which it recently secured a milestone joint development agreement. In addition, shareholders also found […]
Read more